These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 704994)

  • 21. [Delta agent in a Chilean population HBsAg carrier].
    Velasco M; Brahm J; Ponzetto A
    Rev Med Chil; 1985 Jan; 113(1):3-5. PubMed ID: 4081382
    [No Abstract]   [Full Text] [Related]  

  • 22. [HBV serologic markers in the chronic alcoholism (author's transl)].
    Todeschini G; Frandi G; Vicari O; Bontempelli M; Cavagnera A
    Quad Sclavo Diagn; 1981 Jun; 17(2):123-9. PubMed ID: 7267976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interaction of HbsAg with specific anti-HBs immunoglobulin (its use in the determination of immunocomplexes in hepatitis diagnosis)].
    Horejsí J
    Vnitr Lek; 1981 Jul; 27(7):655-9. PubMed ID: 7303499
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatitis B and hepatitis A markers in 33 cases of acute hepatitis B surface antigen-negative, hepatitis A virus antibody-positive viral hepatitis. Importance of immune complexes].
    Raise E; Bonazzi L; Cucci AM; Imbastaro T; Nucci S; Boni P; Miniero R; Lenzi G
    Minerva Med; 1982 Apr; 73(18):1169-72. PubMed ID: 6281689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 28. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.
    Hirohashi S; Shimosato Y; Ino Y; Kishi K
    J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis B surface antigen in various liver diseases in Iraq.
    Al-Balaghi SM; Kassir Z; Thewaini AJ
    J Trop Med Hyg; 1977 Dec; 80(12):248-51. PubMed ID: 606844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum markers of hepatitis B virus and anti-delta antibody in chronic liver disease.
    Buzzelli G; Alterini B; Monaco L; Gialdini D; Baronti E; Matassi L; Simondi P; Zignego AL; Gentilini P
    Quad Sclavo Diagn; 1985 Dec; 21(4):387-98. PubMed ID: 3837913
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibody to hepatitis B core antigen in chronic active hepatitis.
    Bories P; Coursaget P; Goudeau A; Degott C; Maupas P; Benhamou JP
    Br Med J; 1978 Feb; 1(6110):396-7. PubMed ID: 624027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
    Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
    Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on clinical significance in alteration of levels of HBsAg and anti-HBs in chronic aggressive severe hepatitis (author's transl)].
    Yumoto Y; Tanaka Y; Nanba T; Yamada G; Kosaka K
    Kaku Igaku; 1979 Sep; 16(6):857-70. PubMed ID: 522311
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis antigen--antibody tests and their clinical significance.
    Christiansen PA
    J Indiana State Med Assoc; 1977 Nov; 70(11):865-9. PubMed ID: 925357
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hepatitis B markers in Indochinese refugees.
    Chaudhary RK; Nicholls ES; Kennedy DA
    Can Med Assoc J; 1981 Dec; 125(11):1243-6. PubMed ID: 7332883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte hepatitis B surface antigen. Diagnostic evaluation of patients with clinically acute hepatitis B surface antigen-positive hepatitis.
    Su IJ; Kuo TT; Liaw YF
    Arch Pathol Lab Med; 1985 May; 109(5):400-2. PubMed ID: 3885902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic hepatitis B and delta-infection].
    Ketiladze ES; Bugaeva NP; Golosova TV; Kelli EI
    Ter Arkh; 1986; 58(2):63-5. PubMed ID: 3704942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.